Japan· JP-1319717Q1332
クロモグリク酸ナトリウム
A cromoglicic acid product containing クロモグリク酸ナトリウム, registered in Japan by わかもと製薬, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Cromoglicic acid is registered in 6 of 19 countries.
Countries holding a registration under ATC A07EB01 (cromoglicic acid), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Cromoglicic acid · ATC A07EB01
6 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Netherlands
- Norwayprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- クロモグリク酸ナトリウム
- Manufacturer
- わかもと製薬
- Country
- Japan (JP)
- ATC code
- A07EB01
- ATC class
- Cromoglicic acid
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for cromoglicic acid.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cromoglicic acid · interactions on record
130 records
- 5 moderate
- 125 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A07EB01
Cromoglicic acid, as other registers publish it.
- NorwayAllergovalKöhler Pharma
- NorwayCromolyn risingPrasco Laboratories
- FinlandLomudal GastrointestinumItalchimici S.p.A.
- NorwayLomudal GISanofi
- NorwayNalcromGenzyme
- CanadaNALCROMLUPIN PHARMA CANADA LIMITED
- NetherlandsNalcrom, drank 200 mgHormosan Pharma GmbH
- NetherlandsNalcrom, granulaat in sachets 100 mgHormosan Pharma GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6aa2c02-35d5-46c6-8b4d-72a1e16a4207 GET /v1/drugs/c6aa2c02-35d5-46c6-8b4d-72a1e16a4207?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００ｍｇ５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1319717Q1332",
"category": "外用薬",
"price_yen": 167.9,
"generic_name": "クロモグリク酸ナトリウム",
"product_name_jp": null,
"therapeutic_class": "1319",
"transitional_expiry": null
}See everything about cromoglicic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.